Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2006-8-30
pubmed:abstractText
Osteopontin is a multifunctional 34 kDa extracellular matrix protein with a cell-binding domain. It is involved cell adhesion and cell migration and is therefore considered to influence tumorigenesis and/or metastasis. The purpose of the present study was to evaluate the clinical significance of Osteopontin expression in oesophageal squamous cell carcinoma (ESCC). In the present study, we immunohistochemically investigated the relationship between Osteopontin expression and clinicopathological factors including prognosis in surgical specimens of primary tumours in 175 patients with ESCC. Osteopontin was expressed in 48% of 175 patients. Osteopontin expression was significantly correlated with lymph node metastasis, lymphatic invasion, and stage (P=0.0015, 0.037 and 0.033, respectively). Tumours with expressing Osteopontin exhibited more lymph node metastasis, lymphatic invasion and advanced stage than the tumour with negative Osteopontin expression. Five-year survival rate was better in patients with negative Osteopontin expression than in those with positive Osteopontin expression (P=0.035). However, multivariate analysis revealed that Osteopontin expression was not an independent prognostic factor. As our findings suggest that Osteopontin may play an important role in progress of ESCC, the evaluation of Osteopontin expression is useful for predicting the malignant properties of ESCC.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/16880782-10473115, http://linkedlifedata.com/resource/pubmed/commentcorrection/16880782-10861844, http://linkedlifedata.com/resource/pubmed/commentcorrection/16880782-11021631, http://linkedlifedata.com/resource/pubmed/commentcorrection/16880782-11102750, http://linkedlifedata.com/resource/pubmed/commentcorrection/16880782-11357141, http://linkedlifedata.com/resource/pubmed/commentcorrection/16880782-11520606, http://linkedlifedata.com/resource/pubmed/commentcorrection/16880782-11929952, http://linkedlifedata.com/resource/pubmed/commentcorrection/16880782-1421573, http://linkedlifedata.com/resource/pubmed/commentcorrection/16880782-14734468, http://linkedlifedata.com/resource/pubmed/commentcorrection/16880782-15696579, http://linkedlifedata.com/resource/pubmed/commentcorrection/16880782-16015046, http://linkedlifedata.com/resource/pubmed/commentcorrection/16880782-16166420, http://linkedlifedata.com/resource/pubmed/commentcorrection/16880782-7532190, http://linkedlifedata.com/resource/pubmed/commentcorrection/16880782-7542253, http://linkedlifedata.com/resource/pubmed/commentcorrection/16880782-7592829, http://linkedlifedata.com/resource/pubmed/commentcorrection/16880782-8080043, http://linkedlifedata.com/resource/pubmed/commentcorrection/16880782-8560266, http://linkedlifedata.com/resource/pubmed/commentcorrection/16880782-8939661, http://linkedlifedata.com/resource/pubmed/commentcorrection/16880782-9351551, http://linkedlifedata.com/resource/pubmed/commentcorrection/16880782-9425320, http://linkedlifedata.com/resource/pubmed/commentcorrection/16880782-9583725, http://linkedlifedata.com/resource/pubmed/commentcorrection/16880782-9761120
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0007-0920
pubmed:author
pubmed:issnType
Print
pubmed:day
4
pubmed:volume
95
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
634-8
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2006
pubmed:articleTitle
Expression of osteopontin in oesophageal squamous cell carcinoma.
pubmed:affiliation
Department of Surgical Oncology and Digestive Surgery, Field of Oncology, Course of Advanced Therapeutics, Graduate School of Medical and Dental Science, Kagoshima University, Sakuragaoka 8-35-1, Kagoshima 890-8520, Japan. north-y@m.kufm.kagoshima-u.ac.jp
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't